<DOC>
	<DOCNO>NCT01367483</DOCNO>
	<brief_summary>This open-label , radiotracer study , conduct healthy , normal , male volunteer . It entail intravenous administration single dose 14C-MNTX , collection excretion , periodic draw blood sample . Exhaled 14CO2 also sample measure extent possible metabolic MNTX demethylation .</brief_summary>
	<brief_title>Study Pharmacokinetics Intravenous Administered 14C-MNTX</brief_title>
	<detailed_description />
	<mesh_term>Methylnaltrexone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>1 . Males 1845 2 . Subject weight 70 90 kg 3 . In good physical health , evidence screen acute chronic disease likely affect investigation 1 . History evidence cardiovascular , gastrointestinal , hepatic , neurological , pulmonary , renal , significant chronic condition . 2 . Consumption barbiturates inducer inhibitor CYP450 isoforms 3 . History predisposition erratic abnormal bowel function .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>